前のページに戻る この文献は全文を取り寄せることができます
JDreamⅢ複写サービスから文献全文の複写(冊子体のコピー)をお申込みできます。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
既に、G-Searchデータベースサービスまたは、JDreamⅢのIDをお持ちの方
JDreamⅢ複写サービスのご利用が初めての方
取り寄せる文献のタイトルと詳細
文献
J-GLOBAL ID:202102226642033483   整理番号:21A3424367

循環C反応性蛋白質は肺癌リスクを増加させる: 英国バイオバンクの前向きコホートの結果【JST・京大機械翻訳】

Circulating C-reactive protein increases lung cancer risk: Results from a prospective cohort of UK Biobank
著者 (34件):
Ji Mengmeng
(Department of Epidemiology, School of Public Health, Southeast University, Nanjing, China)
Ji Mengmeng
(Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China)
Du Lingbin
(Department of Cancer Prevention, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China)
Du Lingbin
(Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China)
Ma Zhimin
(Department of Epidemiology, School of Public Health, Southeast University, Nanjing, China)
Ma Zhimin
(Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China)
Xie Junxing
(Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China)
Huang Yanqian
(Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China)
Wei Xiaoxia
(Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China)
Jiang Xiangxiang
(Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China)
Xu Jing
(Department of Thoracic Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China)
Yin Rong
(Department of Thoracic Surgery, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China)
Wang Yuzhuo
(Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China)
Wang Yuzhuo
(Department of Thoracic Surgery, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China)
Dai Juncheng
(Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China)
Dai Juncheng
(Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China)
Jin Guangfu
(Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China)
Jin Guangfu
(Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China)
Xu Lin
(Department of Thoracic Surgery, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China)
Zhu Chen
(Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China)
Zhu Chen
(Department of Cancer Prevention, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China)
Zhu Chen
(Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China)
Hu Zhibin
(Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China)
Hu Zhibin
(Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China)
Ma Hongxia
(Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China)
Ma Hongxia
(Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China)
Zhu Meng
(Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China)
Zhu Meng
(Department of Thoracic Surgery, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China)
Zhu Meng
(Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China)
Shen Hongbing
(Department of Epidemiology, School of Public Health, Southeast University, Nanjing, China)
Shen Hongbing
(Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China)
Shen Hongbing
(Department of Cancer Prevention, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China)
Shen Hongbing
(Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China)
Shen Hongbing
(Research Units of Cohort Study on Cardiovascular Diseases and Cancers, Chinese Academy of Medical Sciences, Beijing, China)

資料名:
International Journal of Cancer  (International Journal of Cancer)

巻: 150  号:ページ: 47-55  発行年: 2022年 
JST資料番号: A0267B  ISSN: 0020-7136  資料種別: 逐次刊行物 (A)
記事区分: 原著論文  発行国: アメリカ合衆国 (USA)  言語: 英語 (EN)
JDreamⅢ複写サービスとは
JDreamⅢ複写サービスは、学術文献の全文を複写(コピー)して取り寄せできる有料サービスです。インターネットに公開されていない文献や、図書館に収録されていない文献の全文を、オンラインで取り寄せることができます。J-GLOBALの整理番号にも対応しているので、申し込みも簡単にできます。全文の複写(コピー)は郵送またはFAXでお送りします

※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。